Skip to main content
Erschienen in: Diabetologia 4/2008

01.04.2008 | Article

Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark

verfasst von: J. Grauslund, A. Green, A. K. Sjølie

Erschienen in: Diabetologia | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We evaluated the effect of diabetic retinopathy on 25 year survival rate among a population-based cohort of type 1 diabetic patients from Fyn County, Denmark.

Methods

In 1973 all diabetic patients from Fyn County, Denmark with onset before the age of 30 years as of 1 July 1973 were identified (n = 727). In 1981, only 627 patients were still alive and resident in Denmark. Of these, 573 (91%) participated in a clinical baseline examination, in which diabetic retinopathy was graded and other markers of diabetes measured. Mortality rate was examined in a 25 year follow-up and related to the baseline examination.

Results

Of the 573 patients examined at baseline in 1981 and 1982, 297 (51.8%) were still alive in November 2006. Of the others, 256 (44.7%) had died, three (0.5%) had left Denmark and 17 (3%) were of unknown status. Age- and sex-adjusted HRs of mortality rate were 1.01 (95% CI 0.72–1.42) and 2.04 (1.43–2.91) for patients with non-proliferative and proliferative retinopathy respectively at baseline compared with patients with no retinopathy. After adjusting for proteinuria, HR among patients with proliferative retinopathy lost statistical significance, but still remained 1.48 (95% CI 0.98–2.23). The 10 year survival rate of patients who had proliferative retinopathy as well as proteinuria at baseline was 22.2% and significantly lower (p < 0.001) than in patients with proteinuria only (70.3%), proliferative retinopathy only (79.0%) or neither (86.6%).

Conclusions/interpretation

Proliferative retinopathy and proteinuria predict mortality rate in a population-based cohort of type 1 diabetic patients. In combination they act even more strongly. Non-proliferative diabetic retinopathy did not affect survival rate.
Literatur
1.
Zurück zum Zitat Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49:660–666PubMedCrossRef Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49:660–666PubMedCrossRef
2.
Zurück zum Zitat Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14–S21PubMedCrossRef Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14–S21PubMedCrossRef
3.
Zurück zum Zitat Asao K, Sarti C, Forsen T et al (2003) Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26:2037–2042PubMedCrossRef Asao K, Sarti C, Forsen T et al (2003) Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26:2037–2042PubMedCrossRef
4.
Zurück zum Zitat Laing SP, Swerdlow AJ, Slater SD et al (1999) The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:459–465PubMedCrossRef Laing SP, Swerdlow AJ, Slater SD et al (1999) The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:459–465PubMedCrossRef
5.
Zurück zum Zitat Dorman JS, LaPorte RE, Kuller LH et al (1984) The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33:271–276PubMedCrossRef Dorman JS, LaPorte RE, Kuller LH et al (1984) The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33:271–276PubMedCrossRef
6.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ (1999) Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117:1487–1495PubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ (1999) Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117:1487–1495PubMed
7.
Zurück zum Zitat Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S (2000) High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 23:957–961PubMedCrossRef Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S (2000) High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 23:957–961PubMedCrossRef
8.
Zurück zum Zitat Wong JS, Pearson DW, Murchison LE, Williams MJ, Narayan V (1991) Mortality in diabetes mellitus: experience of a geographically defined population. Diabet Med 8:135–139PubMed Wong JS, Pearson DW, Murchison LE, Williams MJ, Narayan V (1991) Mortality in diabetes mellitus: experience of a geographically defined population. Diabet Med 8:135–139PubMed
9.
Zurück zum Zitat Waugh NR, Dallas JH, Jung RT, Newton RW (1989) Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 32:103–104PubMedCrossRef Waugh NR, Dallas JH, Jung RT, Newton RW (1989) Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 32:103–104PubMedCrossRef
10.
Zurück zum Zitat Henricsson M, Nilsson A, Heijl A, Janzon L, Groop L (1997) Mortality in diabetic patients participating in an ophthalmological control and screening programme. Diabet Med 14:576–583PubMedCrossRef Henricsson M, Nilsson A, Heijl A, Janzon L, Groop L (1997) Mortality in diabetic patients participating in an ophthalmological control and screening programme. Diabet Med 14:576–583PubMedCrossRef
11.
Zurück zum Zitat van Hecke MV, Dekker JM, Stehouwer CD et al (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 28:1383–1389PubMedCrossRef van Hecke MV, Dekker JM, Stehouwer CD et al (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 28:1383–1389PubMedCrossRef
12.
Zurück zum Zitat Klein BE, Klein R, McBride PE et al (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917–1924PubMedCrossRef Klein BE, Klein R, McBride PE et al (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917–1924PubMedCrossRef
13.
Zurück zum Zitat Klein R, Moss SE, Klein BE, DeMets DL (1989) Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266–272PubMedCrossRef Klein R, Moss SE, Klein BE, DeMets DL (1989) Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266–272PubMedCrossRef
14.
Zurück zum Zitat Cusick M, Meleth AD, Agron E et al (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 28:617–625PubMedCrossRef Cusick M, Meleth AD, Agron E et al (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 28:617–625PubMedCrossRef
15.
Zurück zum Zitat Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD (1994) Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 11:968–973PubMedCrossRef Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD (1994) Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 11:968–973PubMedCrossRef
16.
Zurück zum Zitat Davis MD, Hiller R, Magli YL et al (1979) Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc 77:144–170PubMed Davis MD, Hiller R, Magli YL et al (1979) Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc 77:144–170PubMed
17.
Zurück zum Zitat Roy M, Rendas-Baum R, Skurnick J (2006) Mortality in African-Americans with type 1 diabetes: The New Jersey 725. Diabet Med 23:698–706PubMedCrossRef Roy M, Rendas-Baum R, Skurnick J (2006) Mortality in African-Americans with type 1 diabetes: The New Jersey 725. Diabet Med 23:698–706PubMedCrossRef
18.
Zurück zum Zitat Green A, Hauge M, Holm NV, Rasch LL (1981) Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 20:468–470PubMedCrossRef Green A, Hauge M, Holm NV, Rasch LL (1981) Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 20:468–470PubMedCrossRef
19.
Zurück zum Zitat Sjolie AK (1985) Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl 172:1–77PubMed Sjolie AK (1985) Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl 172:1–77PubMed
20.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526PubMed
21.
Zurück zum Zitat Orchard TJ, Dorman JS, Maser RE et al (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116–1124PubMedCrossRef Orchard TJ, Dorman JS, Maser RE et al (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116–1124PubMedCrossRef
22.
Zurück zum Zitat No authors listed (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278–285CrossRef No authors listed (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278–285CrossRef
23.
Zurück zum Zitat Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213PubMedCrossRef Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213PubMedCrossRef
24.
Zurück zum Zitat Klein R, Klein BE, Moss SE (1991) The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344–1348PubMedCrossRef Klein R, Klein BE, Moss SE (1991) The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344–1348PubMedCrossRef
25.
Zurück zum Zitat Ono T, Kobayashi J, Sasako Y et al (2002) The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol 40:428–436PubMedCrossRef Ono T, Kobayashi J, Sasako Y et al (2002) The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol 40:428–436PubMedCrossRef
26.
Zurück zum Zitat Tong PC, Kong AP, So WY et al (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with type 2 diabetes mellitus. Diabet Med 24:741–746PubMedCrossRef Tong PC, Kong AP, So WY et al (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with type 2 diabetes mellitus. Diabet Med 24:741–746PubMedCrossRef
Metadaten
Titel
Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark
verfasst von
J. Grauslund
A. Green
A. K. Sjølie
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 4/2008
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0953-8

Weitere Artikel der Ausgabe 4/2008

Diabetologia 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.